wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33710179-4A85CEDA-7988-4E17-ABAD-599AD55ED769
Q33710179-4A85CEDA-7988-4E17-ABAD-599AD55ED769
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33710179-4A85CEDA-7988-4E17-ABAD-599AD55ED769
Update of IGF-1 receptor inhibitor (ganitumab, dalotuzumab, cixutumumab, teprotumumab and figitumumab) effects on cancer therapy
P2860
Q33710179-4A85CEDA-7988-4E17-ABAD-599AD55ED769
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33710179-4A85CEDA-7988-4E17-ABAD-599AD55ED769
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4acd416fd0cce0c7ac4f7f3137e609c9ec023658
P2860
Randomized, phase III trial of figitumumab in combination with erlotinib versus erlotinib alone in patients with nonadenocarcinoma nonsmall-cell lung cancer.